Laura Lee Sandler
CIK: 0002075401
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Oruka Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (26 total)
- Sep 15, 2026ORKA
Oruka Therapeutics, Inc.
Sale(S)Direct906 shares at avg. $95.71$87K - Sep 1, 2026ORKA
Oruka Therapeutics, Inc.
Sale(S)Direct4K shares at avg. $92.01$368K - Sep 1, 2026ORKA
Oruka Therapeutics, Inc.
Sale(S)Direct1K shares at avg. $91.05$91K - Sep 1, 2026ORKA
Oruka Therapeutics, Inc.
Exercise(M)Direct5K shares at avg. $7.80$39K - Jul 1, 2026ORKA
Oruka Therapeutics, Inc.
Sale(S)Direct2.2K shares at avg. $93.85$210K - Jul 1, 2026ORKA
Oruka Therapeutics, Inc.
Sale(S)Direct2.3K shares at avg. $94.75$214K - Jul 1, 2026ORKA
Oruka Therapeutics, Inc.
Sale(S)Direct500 shares at avg. $95.47$48K - Jul 1, 2026ORKA
Oruka Therapeutics, Inc.
Exercise(M)Direct5K shares at avg. $7.80$39K - Jun 15, 2026ORKA
Oruka Therapeutics, Inc.
Sale(S)Direct600 shares at avg. $69.69$42K - May 1, 2026ORKA
Oruka Therapeutics, Inc.
Sale(S)Direct2.2K shares at avg. $62.58$138K - May 1, 2026ORKA
Oruka Therapeutics, Inc.
Sale(S)Direct1.8K shares at avg. $64.15$115K - May 1, 2026ORKA
Oruka Therapeutics, Inc.
Sale(S)Direct300 shares at avg. $65.10$20K - May 1, 2026ORKA
Oruka Therapeutics, Inc.
Sale(S)Direct400 shares at avg. $66.06$26K - May 1, 2026ORKA
Oruka Therapeutics, Inc.
Sale(S)Direct200 shares at avg. $67.16$13K - May 1, 2026ORKA
Oruka Therapeutics, Inc.
Sale(S)Direct100 shares at avg. $68.48$7K - May 1, 2026ORKA
Oruka Therapeutics, Inc.
Exercise(M)Direct5K shares at avg. $7.80$39K - Mar 16, 2026ORKA
Oruka Therapeutics, Inc.
Sale(S)Direct600 shares at avg. $41.30$25K - Mar 2, 2026ORKA
Oruka Therapeutics, Inc.
Exercise(M)Direct5K shares at avg. $7.80$39K - Mar 2, 2026ORKA
Oruka Therapeutics, Inc.
Sale(S)Direct2.3K shares at avg. $33.28$77K - Mar 2, 2026ORKA
Oruka Therapeutics, Inc.
Sale(S)Direct2.7K shares at avg. $33.81$90K - Jan 23, 2026ORKA
Oruka Therapeutics, Inc.
Award(A)Direct32.5K shares- - Jan 2, 2026ORKA
Oruka Therapeutics, Inc.
Exercise(M)Direct5K shares at avg. $7.80$39K - Jan 2, 2026ORKA
Oruka Therapeutics, Inc.
Sale(S)Direct8.7K shares at avg. $28.17$246K - Jan 2, 2026ORKA
Oruka Therapeutics, Inc.
Sale(S)Direct3.1K shares at avg. $29.08$91K - Jan 2, 2026ORKA
Oruka Therapeutics, Inc.
Sale(S)Direct1.1K shares at avg. $29.75$33K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 15, 2026 | ORKA Oruka Therapeutics, Inc. | Sale(S) | 906 | $95.71 | $86,713 | Direct |
| Sep 1, 2026 | ORKA Oruka Therapeutics, Inc. | Sale(S) | 4,000 | $92.01 | $368,054 | Direct |
| Sep 1, 2026 | ORKA Oruka Therapeutics, Inc. | Sale(S) | 1,000 | $91.05 | $91,048 | Direct |
| Sep 1, 2026 | ORKA Oruka Therapeutics, Inc. | Exercise(M) | 5,000 | $7.80 | $39,000 | Direct |
| Jul 1, 2026 | ORKA Oruka Therapeutics, Inc. | Sale(S) | 2,237 | $93.85 | $209,933 | Direct |
| Jul 1, 2026 | ORKA Oruka Therapeutics, Inc. | Sale(S) | 2,263 | $94.75 | $214,410 | Direct |
| Jul 1, 2026 | ORKA Oruka Therapeutics, Inc. | Sale(S) | 500 | $95.47 | $47,736 | Direct |
| Jul 1, 2026 | ORKA Oruka Therapeutics, Inc. | Exercise(M) | 5,000 | $7.80 | $39,000 | Direct |
| Jun 15, 2026 | ORKA Oruka Therapeutics, Inc. | Sale(S) | 600 | $69.69 | $41,814 | Direct |
| May 1, 2026 | ORKA Oruka Therapeutics, Inc. | Sale(S) | 2,200 | $62.58 | $137,685 | Direct |
| May 1, 2026 | ORKA Oruka Therapeutics, Inc. | Sale(S) | 1,800 | $64.15 | $115,468 | Direct |
| May 1, 2026 | ORKA Oruka Therapeutics, Inc. | Sale(S) | 300 | $65.10 | $19,530 | Direct |
| May 1, 2026 | ORKA Oruka Therapeutics, Inc. | Sale(S) | 400 | $66.06 | $26,422 | Direct |
| May 1, 2026 | ORKA Oruka Therapeutics, Inc. | Sale(S) | 200 | $67.16 | $13,431 | Direct |
| May 1, 2026 | ORKA Oruka Therapeutics, Inc. | Sale(S) | 100 | $68.48 | $6,848 | Direct |
| May 1, 2026 | ORKA Oruka Therapeutics, Inc. | Exercise(M) | 5,000 | $7.80 | $39,000 | Direct |
| Mar 16, 2026 | ORKA Oruka Therapeutics, Inc. | Sale(S) | 600 | $41.30 | $24,780 | Direct |
| Mar 2, 2026 | ORKA Oruka Therapeutics, Inc. | Exercise(M) | 5,000 | $7.80 | $39,000 | Direct |
| Mar 2, 2026 | ORKA Oruka Therapeutics, Inc. | Sale(S) | 2,325 | $33.28 | $77,386 | Direct |
| Mar 2, 2026 | ORKA Oruka Therapeutics, Inc. | Sale(S) | 2,675 | $33.81 | $90,436 | Direct |
| Jan 23, 2026 | ORKA Oruka Therapeutics, Inc. | Award(A) | 32,500 | - | $0 | Direct |
| Jan 2, 2026 | ORKA Oruka Therapeutics, Inc. | Exercise(M) | 5,000 | $7.80 | $39,000 | Direct |
| Jan 2, 2026 | ORKA Oruka Therapeutics, Inc. | Sale(S) | 8,748 | $28.17 | $246,396 | Direct |
| Jan 2, 2026 | ORKA Oruka Therapeutics, Inc. | Sale(S) | 3,144 | $29.08 | $91,432 | Direct |
| Jan 2, 2026 | ORKA Oruka Therapeutics, Inc. | Sale(S) | 1,108 | $29.75 | $32,967 | Direct |
1-25 of 26 transactions
About Sandler Laura Lee
Sandler Laura Lee (SEC CIK 0002075401) files insider reports with the SEC as Chief Operating Officer of Oruka Therapeutics, Inc. (ORKA).
Signal8 holds 11 ownership filings by Sandler Laura Lee (1 Form 3, 10 Form 4), filed between Jul 1, 2025 and Sep 15, 2026. Those filings report 26 transactions, from Jul 1, 2025 to Sep 15, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Sandler Laura Lee's filings is in MENLO PARK, CA.
Recent filings by Sandler Laura Lee
- Sep 15, 2026: Open-market sale of ORKA shares (Form 4, code S).
- Sep 1, 2026: Open-market sales of ORKA shares (2 lines, Form 4, code S).
- Sep 1, 2026: Option exercise of ORKA shares (Form 4, code M).
- Jul 1, 2026: Open-market sales of ORKA shares (3 lines, Form 4, code S).
- Jul 1, 2026: Option exercise of ORKA shares (Form 4, code M).
Other insiders filing for Oruka Therapeutics, Inc. (ORKA)
- Klein Lawrence Otto, Chief Executive Officer
- Quinlan Paul T, General Counsel
- Goncalves Joana, Chief Medical Officer
- Agarwal Arjun, Senior Vice President, Finance
- Edwards Larry Todd, Chief Commercial Officer
- Fairmount Funds Management LLC, Director